Bullboard - Stock Discussion Forum Oragenics Inc OGEN

Healthcare Biotechnology

Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It is focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for... see more

Add To Watchlist

NYSEAM:OGEN - Post Discussion

Oragenics Inc > Oragenics Announces Termination of At-The-Market Offering Pr

View:

Post by whytestocks on Jan 23, 2024 9:45pm

Oragenics Announces Termination of At-The-Market Offering Pr

NEWS: $OGEN Oragenics Announces Termination of At-The-Market Offering ProgramOragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced it has terminated its previously announced “at-the-market” (“ATM”) equity offering program. The Company has initiated the 5-day termination process of t...OGEN - Oragenics Announces Termination of At-The-Market Offering Program